Literature DB >> 28935576

Myofilament Remodeling and Function Is More Impaired in Peripartum Cardiomyopathy Compared with Dilated Cardiomyopathy and Ischemic Heart Disease.

Ilse A E Bollen1, Elisabeth Ehler2, Karin Fleischanderl2, Floor Bouwman3, Lanette Kempers3, Melanie Ricke-Hoch4, Denise Hilfiker-Kleiner4, Cristobal G Dos Remedios5, Martina Krüger6, Aryan Vink7, Folkert W Asselbergs8, Karin Y van Spaendonck-Zwarts9, Yigal M Pinto10, Diederik W D Kuster11, Jolanda van der Velden12.   

Abstract

Peripartum cardiomyopathy (PPCM) and dilated cardiomyopathy (DCM) show similarities in clinical presentation. However, although DCM patients do not recover and slowly deteriorate further, PPCM patients show either a fast cardiac deterioration or complete recovery. The aim of this study was to assess if underlying cellular changes can explain the clinical similarities and differences in the two diseases. We, therefore, assessed sarcomeric protein expression, modification, titin isoform shift, and contractile behavior of cardiomyocytes in heart tissue of PPCM and DCM patients and compared these with nonfailing controls. Heart samples from ischemic heart disease (ISHD) patients served as heart failure control samples. Passive force was only increased in PPCM samples compared with controls, whereas PPCM, DCM, and ISHD samples all showed increased myofilament Ca2+ sensitivity. Length-dependent activation was significantly impaired in PPCM compared with controls, no impairment was observed in ISHD samples, and DCM samples showed an intermediate response. Contractile impairments were caused by impaired protein kinase A (PKA)-mediated phosphorylation because exogenous PKA restored all parameters to control levels. Although DCM samples showed reexpression of EH-myomesin, an isoform usually only expressed in the heart before birth, PPCM and ISHD did not. The lack of EH-myomesin, combined with low PKA-mediated phosphorylation of myofilament proteins and increased compliant titin isoform, may explain the increase in passive force and blunted length-dependent activation of myofilaments in PPCM samples.
Copyright © 2017 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28935576     DOI: 10.1016/j.ajpath.2017.08.022

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  12 in total

1.  Defining decreased protein succinylation of failing human cardiac myofibrils in ischemic cardiomyopathy.

Authors:  Hadi R Ali; Cole R Michel; Ying H Lin; Timothy A McKinsey; Mark Y Jeong; Amrut V Ambardekar; Joseph C Cleveland; Richard Reisdorph; Nichole Reisdorph; Kathleen C Woulfe; Kristofer S Fritz
Journal:  J Mol Cell Cardiol       Date:  2019-12-10       Impact factor: 5.000

2.  Cardiomyocyte Hypocontractility and Reduced Myofibril Density in End-Stage Pediatric Cardiomyopathy.

Authors:  Ilse A E Bollen; Marijke van der Meulen; Kyra de Goede; Diederik W D Kuster; Michiel Dalinghaus; Jolanda van der Velden
Journal:  Front Physiol       Date:  2017-12-22       Impact factor: 4.566

Review 3.  Peripartum Cardiomyopathy: an Update.

Authors:  Feriel Azibani; Karen Sliwa
Journal:  Curr Heart Fail Rep       Date:  2018-10

Review 4.  Cardiomyopathies and Related Changes in Contractility of Human Heart Muscle.

Authors:  Petr G Vikhorev; Natalia N Vikhoreva
Journal:  Int J Mol Sci       Date:  2018-07-31       Impact factor: 5.923

5.  Protein Quality Control Activation and Microtubule Remodeling in Hypertrophic Cardiomyopathy.

Authors:  Larissa M Dorsch; Maike Schuldt; Cristobal G dos Remedios; Arend F L Schinkel; Peter L de Jong; Michelle Michels; Diederik W D Kuster; Bianca J J M Brundel; Jolanda van der Velden
Journal:  Cells       Date:  2019-07-18       Impact factor: 6.600

6.  End-diastolic force pre-activates cardiomyocytes and determines contractile force: role of titin and calcium.

Authors:  Aref Najafi; Martijn van de Locht; Maike Schuldt; Patrick Schönleitner; Menne van Willigenburg; Ilse Bollen; Max Goebel; Coen A C Ottenheijm; Jolanda van der Velden; Michiel Helmes; Diederik W D Kuster
Journal:  J Physiol       Date:  2019-07-30       Impact factor: 5.182

Review 7.  Posttranslational modifications of titin from cardiac muscle: how, where, and what for?

Authors:  Franziska Koser; Christine Loescher; Wolfgang A Linke
Journal:  FEBS J       Date:  2019-04-29       Impact factor: 5.542

Review 8.  The M-band: The underestimated part of the sarcomere.

Authors:  Stephan Lange; Nikos Pinotsis; Irina Agarkova; Elisabeth Ehler
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2019-02-07       Impact factor: 4.739

9.  Heterozygous loss of Rbm24 in the adult mouse heart increases sarcomere slack length but does not affect function.

Authors:  N E de Groot; M M G van den Hoogenhof; A Najafi; I van der Made; J van der Velden; A Beqqali; Y M Pinto; E E Creemers
Journal:  Sci Rep       Date:  2020-05-06       Impact factor: 4.379

10.  Titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation.

Authors:  Petr G Vikhorev; Natalia N Vikhoreva; WaiChun Yeung; Amy Li; Sean Lal; Cristobal G Dos Remedios; Cheavar A Blair; Maya Guglin; Kenneth S Campbell; Magdi H Yacoub; Pieter de Tombe; Steven B Marston
Journal:  Cardiovasc Res       Date:  2022-01-07       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.